Elevation of transforming growth factor beta (TGFβ) and its downstream mediators in subcutaneous foreign body capsule tissue
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Foreign body encapsulation represents a chronic fibrotic response and has been a major obstacle that reduces the useful life of implanted biomedical devices. The precise mechanism underlying such an encapsulation is still unknown. We hypothesized that, considering its central role in many other fibrotic conditions, transforming growth factor β (TGFβ) may play an important role during the formation of foreign body capsule (FBC). In the present study, we implanted mock sensors in rats subcutaneously and excised FBC samples at day 7, 21, and 48–55 postimplantation. The most abundant TGFβ isoform in all tissues was TGFβ1, which was expressed minimally in control tissue. The expression of both TGFβ1 RNA and protein was significantly increased in FBC tissues at all time points, with the highest level in day 7 FBC. The number of cells stained for phosphorylated Smad2, an indication of activated TGFβ signaling, paralleled the expression of TGFβ. A similar dynamic change was also observed in the numbers of FBC myofibroblasts, which in response to TGFβ, differentiate from quiescent fibroblasts and synthesize collagen. Type I collagen, the most prominent downstream target of TGFβ in fibrosis, was found in abundance in the FBC, especially during the latter time periods. We suggest that TGFβ plays an important role in the FBC formation. Inhibition of TGFβ signaling could be a promising strategy in the prevention of FBC formation, thereby extending the useful life of subcutaneous implants. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry
Brodbeck, W. G., Voskerician, G., Ziats, N. P., Nakayama, Y., Matsuda, T., & Anderson, J. M. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10425 · Cited by 181
Ward, W. K., Slobodzian, E. P., Tiekotter, K. L., & Wood, M. D. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00160-6 · Cited by 176
Self-citation
Cited by
The myofibroblast: Paradigm for a mechanically active cell
Hinz, B. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.09.020 · Cited by 698
Martin, K. E., & García, A. J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.038 · Cited by 367
Ward, W. K. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200504 · Cited by 325
Self-citationDomesticating the foreign body response: recent advances and applications
Veiseh, O., & Vegas, A. J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.08.010 · Cited by 245
Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction
Noskovicova, N., Hinz, B., & Pakshir, P. (2021) · Cells · doi:10.3390/cells10071794 · Cited by 184
Metadata
- Authors
- Li, A. G., Quinn, M. J., Siddiqui, Y., Wood, M. D., Federiuk, I. F., Duman, H. M., & Ward, W. K.
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2007-02-12
- Volume
- 82A
- Issue
- 2
- Pages
- 498-508
- ISSN
- 1549-3296 (ISSN-L)
- 1552-4965
- OpenAlex
- W2063447333
- Cited by
- 42
- References
- 5
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.